Pemigatinib-associated calcinosis cutis: First case of complete regression with continued phosphate chelator therapy

Ann Dermatol Venereol. 2024 Sep;151(3):103304. doi: 10.1016/j.annder.2024.103304. Epub 2024 Aug 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Calcinosis Cutis
  • Calcinosis* / chemically induced
  • Calcinosis* / pathology
  • Chelating Agents* / adverse effects
  • Chelating Agents* / therapeutic use
  • Female
  • Humans
  • Male
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use
  • Skin Diseases / chemically induced
  • Skin Diseases / pathology

Substances

  • Chelating Agents
  • Pyrimidines